U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662200) titled 'A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy' on May 21.
Brief Summary: This is a single-site, open-label, randomized pilot feasibility study conducted at The Ottawa Hospital Cancer Centre. A total of 10 participants will be randomized 1:1 to either the experimental or control arm.
The purpose of this study is to evaluate recruitment capability, intervention adherence, data completeness, and safety prior to consideration of a potential future multi-centre randomized trial.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
G...